Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02 juin 2023 16h00 HE | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., June 02, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 31, 2023 it granted stock options to purchase an aggregate of...
AquaBounty_Blue_Flat_SPOT2995_FINAL.png
AquaBounty Announces a Pause to Ohio Farm Construction While It Evaluates Scope Alternatives and a Possible Phased Approach
02 juin 2023 08h00 HE | AquaBounty Technologies, Inc.
MAYNARD, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance...
Bluejay_primary_logo.png
Bluejay Therapeutics Advances in Hepatitis B and D Trials: Successfully Completes BJT-778 Phase 1a Study and Begins Phase 1b Trial Enrollment
01 juin 2023 18h14 HE | Bluejay Therapeutics
SAN MATEO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a company dedicated to developing innovative treatments for viral and liver diseases, announces the successful completion...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics to Participate in Upcoming Investor Conferences
01 juin 2023 16h00 HE | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor...
Recursion to Partici
Recursion to Participate in Upcoming Investor Conferences
01 juin 2023 08h30 HE | Recursion Pharmaceuticals
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
Madrigal logo.jpg
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
01 juin 2023 08h00 HE | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., June 01, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic...
ADCT_4C_TM.png
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
01 juin 2023 07h15 HE | ADC Therapeutics SA
LAUSANNE, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
JnanaTherapeutics_Logo_FullColor_RGB.png
Jnana Therapeutics to Present at the Jefferies Healthcare Conference
01 juin 2023 07h00 HE | Jnana Therapeutics, Inc.
BOSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
NEW ATAI-Logo_Primary.png
atai Life Sciences to Participate in Upcoming June Investor Conferences
01 juin 2023 06h59 HE | atai Life Sciences
NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health...
logo_RGB[hr] (1).jpg
BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data
01 juin 2023 03h00 HE | BC Platforms
ZURICH, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the acquisition of 4Pharma Ltd, a...